Byron S Alberty, DPM
Podiatry · La Mirada
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 29 years
- California School of Podiatric Medicine, 1997
Offices
3 locations · Pih Health Physicians · 616 clinicians in this group
Hospitals listed: Pih Health Downey Hospital · Pih Health Hospital-Whittier. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alberty’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pih Health Downey HospitalDowney, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of PIH Health, which runs 3 hospitalsPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
See every measure and the patient survey for Pih Health Downey Hospital
Behind the star rating — Deaths: 1 better, 5 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.21 to 2.34) · 403 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.44 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 178 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.9 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.1 · 160 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,052 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,633 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,714 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (0.61 to 5.59) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.89 (0 to 18.8) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.46) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.22) · 2,012 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.198 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 124 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.1 · 614 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.7 · 229 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.5 · 234 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.3 to 16.8) · 432 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 156 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,108 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$55,268
Medicare paid this office $55,268 for 323 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 158 | $14,601 | $69 |
| New patient visit (30+ min) | 160 | $13,329 | $83 |
| X-ray of foot, minimum of 3 views | 127 | $5,066 | $29 |
| Removal of fingernails or toenails, 6 or more nails | 66 | $4,241 | $38 |
| Permanent removal fingernail or toenail | 26 | $3,807 | $131 |
See all 8 services
| Short return visit (20+ min) | 158 | $14,601 | $69 |
| New patient visit (30+ min) | 160 | $13,329 | $83 |
| X-ray of foot, minimum of 3 views | 127 | $5,066 | $29 |
| Removal of fingernails or toenails, 6 or more nails | 66 | $4,241 | $38 |
| Permanent removal fingernail or toenail | 26 | $3,807 | $131 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $2,271 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,690 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,371 | $65 |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of nail tissue | 263 | More than 77% of doctors who do this |
| Removal of tissue | 21 | More than 70% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of fingernails or toenails, 6 or more nails | 114 | 116 | 130 | 109 | 85 | 113 |
| Permanent removal fingernail or toenail | 62 | 38 | 47 | 52 | 39 | 29 |
| Removal of noncancer thickened skin growth, 1 growth | 17 | – | – | – | – | – |
| Simple separation of fingernail or toenail from nail bed, first nail | 14 | – | – | – | – | – |
| Placement of strapping to ankle or foot | 13 | – | – | – | – | – |
| Application of short leg splint from calf to foot | – | – | 12 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
323 Original Medicare patients in 2024. Average age 74 · Under 65 14% · 85 and older 15% · Women 57% · Also on Medicaid 31% · Health risk score 2.04. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 52% · Chronic kidney disease 35% · Coronary heart disease 21% · Depression 21% · Heart failure 20% · Atrial fibrillation 17% · COPD 16% · Cancer 14% · Stroke 11% · Dementia 9%.
The office billed $231,063, Medicare allowed $75,645 and paid $55,268; for 967 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 323 | 967 | 74 | 2.04 | $231,063 | $55,268 |
| 2023 | 334 | 994 | 73 | 1.93 | $260,003 | $59,360 |
| 2022 | 332 | 1,031 | 72 | 1.72 | $257,487 | $68,310 |
| 2021 | 311 | 1,023 | 73 | 1.72 | $224,679 | $64,761 |
| 2020 | 279 | 889 | 73 | 1.99 | $179,912 | $48,266 |
| 2019 | 308 | 1,210 | 73 | 1.85 | $250,520 | $65,768 |
| 2018 | 242 | 1,125 | 73 | 1.96 | $210,795 | $51,191 |
| 2017 | 235 | 1,042 | 74 | 1.84 | $182,524 | $46,803 |
| 2016 | 233 | 1,012 | 73 | 1.78 | $180,766 | $47,840 |
| 2015 | 224 | 1,051 | 73 | 1.83 | $221,128 | $58,712 |
| 2014 | 195 | 966 | 74 | 1.71 | $168,934 | $46,487 |
| 2013 | 201 | 876 | 73 | 1.44 | $148,003 | $41,064 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Short return visit (20+ min) | 155 | $16,013 | $70 |
| New patient visit (30+ min) | 174 | $14,537 | $84 |
| X-ray of foot, minimum of 3 views | 139 | $5,535 | $28 |
| Permanent removal fingernail or toenail | 34 | $5,189 | $133 |
| Removal of tissue from wound, 20.0 sq cm or less | 15 | $3,534 | $91 |
| Removal of fingernails or toenails, 6 or more nails | 59 | $3,145 | $37 |
| X-ray of ankle, minimum of 3 views | 12 | $348 | $25 |
2022: 8 services
| Short return visit (20+ min) | 154 | $17,953 | $71 |
| New patient visit (30+ min) | 173 | $14,591 | $84 |
| Permanent removal fingernail or toenail | 42 | $7,113 | $137 |
| X-ray of foot, minimum of 3 views | 129 | $6,403 | $30 |
| Removal of tissue from wound, 20.0 sq cm or less | 19 | $4,948 | $87 |
| Removal of fingernails or toenails, 6 or more nails | 68 | $3,928 | $36 |
| New patient visit (15+ min) | 12 | $519 | $43 |
| X-ray of ankle, minimum of 3 views | 12 | $443 | $32 |
2021: 10 services
| Short return visit (20+ min) | 144 | $16,222 | $75 |
| New patient visit (30+ min) | 145 | $12,724 | $88 |
| Permanent removal fingernail or toenail | 35 | $6,369 | $136 |
| X-ray of foot, minimum of 3 views | 134 | $6,201 | $30 |
| Removal of tissue from wound, 20.0 sq cm or less | 25 | $5,864 | $89 |
| Removal of fingernails or toenails, 6 or more nails | 81 | $4,787 | $37 |
| New patient visit (15+ min) | 33 | $1,843 | $56 |
| Application of short leg splint from calf to foot | 12 | $714 | $60 |
| X-ray of ankle, minimum of 3 views | 15 | $621 | $33 |
| Cast supplies, short leg splint, adult (11 years +), fiberglass | 12 | $86 | $7 |
2020: 8 services
| Short return visit (20+ min) | 134 | $12,999 | $60 |
| New patient visit (30+ min) | 110 | $8,924 | $81 |
| Permanent removal fingernail or toenail | 28 | $5,146 | $135 |
| Removal of fingernails or toenails, 6 or more nails | 68 | $4,338 | $37 |
| X-ray of foot, minimum of 3 views | 97 | $4,230 | $28 |
| Removal of tissue from wound, 20.0 sq cm or less | 18 | $3,206 | $82 |
| New patient visit (15+ min) | 33 | $1,815 | $55 |
| X-ray of ankle, minimum of 3 views | 12 | $425 | $30 |
2019: 12 services
| Short return visit (20+ min) | 153 | $16,078 | $62 |
| New patient visit (30+ min) | 132 | $11,487 | $87 |
| Permanent removal fingernail or toenail | 54 | $8,388 | $135 |
| X-ray of foot, minimum of 3 views | 123 | $5,559 | $28 |
| Removal of fingernails or toenails, 6 or more nails | 66 | $4,399 | $39 |
| New patient visit (15+ min) | 58 | $3,445 | $59 |
| Removal of tissue from wound, 20.0 sq cm or less | 17 | $2,745 | $83 |
| Simple separation of fingernail or toenail from nail bed, first nail | 13 | $1,330 | $95 |
| Removal of noncancer thickened skin growth, 1 growth | 15 | $876 | $52 |
| X-ray of ankle, minimum of 3 views | 16 | $619 | $31 |
| Placement of strapping to ankle or foot | 11 | $285 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $230 | None |
2018: 10 services
| Short return visit (20+ min) | 130 | $14,002 | $56 |
| New patient visit (30+ min) | 113 | $9,372 | $83 |
| X-ray of foot, minimum of 3 views | 131 | $6,508 | $24 |
| Permanent removal fingernail or toenail | 32 | $5,738 | $133 |
| Removal of fingernails or toenails, 6 or more nails | 39 | $2,912 | $38 |
| New patient visit (15+ min) | 32 | $1,818 | $57 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $1,337 | $64 |
| Simple separation of fingernail or toenail from nail bed, first nail | 12 | $1,235 | $95 |
| X-ray of ankle, minimum of 3 views | 11 | $487 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $267 | None |
2017: 8 services
| New patient visit (30+ min) | 134 | $10,762 | $80 |
| Short return visit (20+ min) | 97 | $10,511 | $62 |
| X-ray of foot, minimum of 3 views | 171 | $8,753 | $24 |
| Permanent removal fingernail or toenail | 26 | $4,054 | $123 |
| Return visit (30+ min) | 45 | $3,643 | $65 |
| Removal of fingernails or toenails, 6 or more nails | 18 | $1,304 | $38 |
| X-ray of ankle, minimum of 3 views | 21 | $1,225 | $28 |
| New patient visit (15+ min) | 17 | $1,030 | $61 |
2016: 6 services
| Return visit (30+ min) | 109 | $13,808 | $83 |
| New patient visit (30+ min) | 164 | $13,519 | $82 |
| X-ray of foot, minimum of 3 views | 152 | $7,859 | $23 |
| Permanent removal fingernail or toenail | 27 | $4,950 | $155 |
| X-ray of ankle, minimum of 3 views | 24 | $1,247 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $258 | None |
2015: 6 services
| Return visit (30+ min) | 105 | $16,998 | $87 |
| New patient visit (30+ min) | 155 | $12,690 | $82 |
| X-ray of foot, minimum of 3 views | 160 | $8,791 | $25 |
| Permanent removal fingernail or toenail | 31 | $7,897 | $188 |
| X-ray of ankle, minimum of 3 views | 26 | $1,551 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $183 | None |
2014: 8 services
| New patient visit (30+ min) | 133 | $11,287 | $85 |
| X-ray of foot, minimum of 3 views | 135 | $8,323 | $28 |
| Short return visit (20+ min) | 70 | $8,158 | $55 |
| Return visit (30+ min) | 42 | $5,586 | $90 |
| Permanent removal fingernail or toenail | 19 | $4,038 | $176 |
| X-ray of ankle, minimum of 3 views | 23 | $1,385 | $27 |
| Removal of fingernails or toenails, 6 or more nails | 14 | $932 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $218 | None |
2013: 6 services
| New patient visit (30+ min) | 133 | $11,052 | $83 |
| X-ray of foot, minimum of 3 views | 145 | $8,324 | $27 |
| Short return visit (20+ min) | 68 | $7,910 | $59 |
| Permanent removal fingernail or toenail | 26 | $5,261 | $188 |
| New patient visit (15+ min) | 21 | $1,287 | $61 |
| X-ray of ankle, minimum of 3 views | 20 | $1,179 | $28 |
Medicaid work
$1,099 in 2023
Medicaid paid $1,099 for 14 billed services this clinician did in 2023, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 14 | $1,099 |
| 2023 | 14 | 1 | 14 | $1,099 |
| 2022 | 12 | 1 | 12 | $543 |
| 2020 | 56 | 3 | 18 | $1,902 |
| 2019 | 92 | 3 | 24 | $3,889 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 12 | $543 |
2020
| New patient visit (30+ min) | 12 | $1,070 |
| Short return visit (20+ min) | 20 | $784 |
| X-RAY EXAM OF FOOT | 24 | $48 |
2019
| New patient visit (30+ min) | 23 | $2,338 |
| Short return visit (20+ min) | 34 | $1,527 |
| X-RAY EXAM OF FOOT | 35 | $24 |
Drugs they prescribed that Part D paid
$12,690
Pharmacies billed $12,690 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (74 of 650) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
632 generic and 18 brand-name prescriptions · $12,690 in drug cost · 116 antibiotic prescriptions to 103 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciclopirox | 203 | $5,064 | $17 |
| Betamethasone Diprop Augmented | 22 | $1,644 | $59 |
| Terbinafine | 31 | $1,161 | $18 |
| Hydrocodone-Acetaminophen | 47 | $904 | $17 |
| Amoxicillin-Clavulanate Potass | 90 | $743 | $8 |
See all 6 drugs
| Ciclopirox | 203 | $5,064 | $17 |
| Betamethasone Diprop Augmented | 22 | $1,644 | $59 |
| Terbinafine | 31 | $1,161 | $18 |
| Hydrocodone-Acetaminophen | 47 | $904 | $17 |
| Amoxicillin-Clavulanate Potass | 90 | $743 | $8 |
| Gabapentin | 36 | $169 | $4 |
Year by year
| 2024 | 650 | 432 | 11% (74) | 3% | $12,690 |
| 2023 | 523 | 364 | 6% (31) | 3% | $13,068 |
| 2022 | 602 | 398 | 6% (38) | 4% | $18,863 |
| 2021 | 555 | 346 | 5% (28) | 4% | $21,526 |
| 2020 | 503 | 363 | 3% (16) | 7% | $14,543 |
| 2019 | 508 | 298 | 7% (36) | 6% | $16,152 |
| 2018 | 425 | 256 | 10% (44) | 6% | $11,724 |
| 2017 | 302 | 208 | 9% (26) | 5% | $6,462 |
| 2016 | 286 | 186 | 14% (41) | None | $7,960 |
| 2015 | 274 | 169 | 13% (36) | 12% | $11,289 |
| 2014 | 305 | 157 | 11% (33) | 10% | $12,298 |
| 2013 | 255 | 159 | 11% (29) | None | $11,957 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Ciclopirox | 212 | $6,342 | $30 |
| Betamethasone Diprop Augmented | 27 | $2,251 | $83 |
| Terbinafine | 48 | $1,782 | $37 |
| Amoxicillin-Clavulanate Potass | 105 | $1,380 | $13 |
| Hydrocodone-Acetaminophen | 27 | $323 | $12 |
| Clindamycin | 18 | $249 | $14 |
| Gabapentin | 43 | $174 | $4 |
2022: 9 drugs
| Ciclopirox | 200 | $5,355 | $27 |
| Betamethasone Diprop Augmented | 40 | $3,778 | $94 |
| Vancomycin | 12 | $3,052 | $254 |
| Amoxicillin-Clavulanate Potass | 153 | $2,272 | $15 |
| Terbinafine | 52 | $1,343 | $26 |
| Clindamycin | 23 | $461 | $20 |
| Hydrocodone-Acetaminophen | 34 | $386 | $11 |
| Methylprednisolone | 20 | $197 | $10 |
| Gabapentin | 25 | $89 | $4 |
2021: 10 drugs
| Vancomycin | 28 | $6,215 | $222 |
| Ciclopirox | 143 | $4,226 | $30 |
| Betamethasone Diprop Augmented | 37 | $3,059 | $83 |
| Amoxicillin-Clavulanate Potass | 149 | $1,738 | $12 |
| Terbinafine | 42 | $1,059 | $25 |
| Clindamycin | 25 | $439 | $18 |
| Methylprednisolone | 34 | $342 | $10 |
| Hydrocodone-Acetaminophen | 27 | $277 | $10 |
| Levofloxacin | 14 | $62 | $4 |
| Gabapentin | 11 | $34 | $3 |
2020: 10 drugs
| Betamethasone Diprop Augmented | 37 | $3,274 | $88 |
| Ciclopirox | 124 | $3,249 | $26 |
| Diclofenac | 46 | $2,601 | $57 |
| Amoxicillin-Clavulanate Potass | 140 | $1,714 | $12 |
| Terbinafine | 53 | $1,084 | $20 |
| Imiquimod | 11 | $819 | $74 |
| Clindamycin | 14 | $225 | $16 |
| Methylprednisolone | 18 | $162 | $9 |
| Hydrocodone-Acetaminophen | 15 | $155 | $10 |
| Gabapentin | 16 | $71 | $4 |
2019: 11 drugs
| Betamethasone Diprop Augmented | 29 | $2,608 | $90 |
| Vancomycin | 12 | $2,508 | $209 |
| Amoxicillin-Clavulanate Potass | 138 | $2,436 | $18 |
| Terbinafine | 81 | $2,288 | $28 |
| Ciclopirox | 74 | $2,084 | $28 |
| Imiquimod | 21 | $1,713 | $82 |
| Methylprednisolone | 26 | $364 | $14 |
| Hydrocodone-Acetaminophen | 33 | $336 | $10 |
| Clindamycin | 13 | $198 | $15 |
| Gabapentin | 24 | $128 | $5 |
| Levofloxacin | 11 | $125 | $11 |
2018: 8 drugs
| Betamethasone Diprop Augmented | 19 | $1,916 | $101 |
| Amoxicillin-Clavulanate Potass | 108 | $1,859 | $17 |
| Ciclopirox | 67 | $1,724 | $26 |
| Terbinafine | 60 | $1,534 | $26 |
| Hydrocodone-Acetaminophen | 40 | $801 | $20 |
| Methylprednisolone | 33 | $459 | $14 |
| Clindamycin | 14 | $146 | $10 |
| Gabapentin | 22 | $131 | $6 |
2017: 6 drugs
| Terbinafine | 67 | $1,669 | $25 |
| Amoxicillin-Clavulanate Potass | 87 | $1,432 | $16 |
| Betamethasone Dipropionate | 14 | $1,079 | $77 |
| Ciclopirox | 26 | $710 | $27 |
| Methylprednisolone | 36 | $428 | $12 |
| Hydrocodone-Acetaminophen | 21 | $299 | $14 |
2016: 6 drugs
| Terbinafine | 66 | $1,570 | $24 |
| Amoxicillin-Clavulanate Potass | 68 | $1,360 | $20 |
| Betamethasone Dipropionate | 15 | $1,338 | $89 |
| Hydrocodone-Acetaminophen | 37 | $1,182 | $32 |
| Ciclopirox | 20 | $678 | $34 |
| Methylprednisolone | 33 | $546 | $17 |
2015: 6 drugs
| Amoxicillin-Clavulanate Potass | 81 | $1,597 | $20 |
| Hydrocodone-Acetaminophen | 21 | $1,465 | $70 |
| Voltaren | 24 | $1,316 | $55 |
| Terbinafine | 57 | $1,255 | $22 |
| Methylprednisolone | 21 | $340 | $16 |
| Cephalexin | 12 | $109 | $9 |
2014: 7 drugs
| Betamethasone Dipropionate | 28 | $2,792 | $100 |
| Terbinafine | 82 | $1,869 | $23 |
| Hydrocodone-Acetaminophen | 21 | $1,537 | $73 |
| Ciclopirox | 38 | $1,285 | $34 |
| Amox Tr-Potassium Clavulanate | 47 | $945 | $20 |
| Methylprednisolone | 20 | $411 | $21 |
| Levofloxacin | 16 | $335 | $21 |
2013: 6 drugs
| Terbinafine | 67 | $1,432 | $21 |
| Amox Tr-Potassium Clavulanate | 52 | $1,420 | $27 |
| Betamethasone Dipropionate | 14 | $1,390 | $99 |
| Ciclopirox | 29 | $586 | $20 |
| Methylprednisolone | 19 | $440 | $23 |
| Hydrocodone-Acetaminophen | 24 | $201 | $8 |
Money from drug and device companies
$299 in 2025
| 2025 | 2 | 2 | None | $299 |
| 2024 | 1 | 3 | None | $382 |
| 2023 | 1 | 1 | None | $21 |
| 2022 | 3 | 3 | None | $273 |
| 2021 | 3 | 15 | None | $960 |
| 2020 | 2 | 2 | None | $26 |
| 2019 | 4 | 5 | None | $734 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotissue Holdings | None | $213 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System 1 | $87 | 1 payment
|
See all 2 published payments
| Treace Medical Concepts | Meals · 2025-06-21 | Lapiplasty System 1 | $87 |
| Biotissue Holdings | Meals · 2025-05-15 | None | $213 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $382
| Biotissue Holdings | None | $382 | 3 payments
|
2023: $21
| Abbott Laboratories | Proclaim | $21 | 1 payment
|
2022: $273
| BioTissue Holdings | Neox | $117 | 1 payment
|
| Paragon 28 | Product Portfolio | $113 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System | $44 | 1 payment
|
2021: $960
| Treace Medical Concepts | Lapiplasty System | $362 | 5 payments
|
| Arthrex | None | $342 | 7 payments
|
| Tissuetech | Neox | $256 | 3 payments
|
2020: $26
| Smith+Nephew | Santyl | $16 | 1 payment
|
| Amniox Medical | Neox | $10 | 1 payment
|
2019: $734
| Treace Medical Concepts | Lapiplasty System | $557 | 2 payments
|
| Paragon 28 | None | $101 | 1 payment
|
| Amniox Medical | Neox | $55 | 1 payment
|
| Osiris Therapeutics | Stravix | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1477654614
- Licence
- CA E4178
- Trained
- California School of Podiatric Medicine, 1997 · 29 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 000E41780
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 15141 Whittier Blvd, Suite 200, Whittier, CA, 90603
- NPI first listed
- 2006-09-26
- NPI last updated
- 2008-05-15
This is when the NPI record was last certified, not a medical board exam.